Other Assets, Noncurrent in USD of aTYR PHARMA INC from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
aTYR PHARMA INC quarterly Other Assets, Noncurrent history and change rate from Q4 2014 to Q3 2025.
  • aTYR PHARMA INC Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $149K, a 14.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

aTYR PHARMA INC Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $149K +$19K +14.6% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $66K -$64K -49.2% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $66K -$64K -49.2% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $66K -$65K -49.6% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $130K +$57K +78.1% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $130K +$58K +80.6% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $130K -$14K -9.72% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $131K -$62K -32.1% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $73K -$96K -56.8% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $72K -$103K -58.9% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $144K -$32K -18.2% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $193K +$35K +22.2% 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 $169K +$11K +6.96% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $175K +$23K +15.1% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $176K -$58K -24.8% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $158K -$55K -25.8% 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $158K +$18K +12.9% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $152K +$27K +21.6% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $234K +$85K +57% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $213K +$41K +23.8% 31 Dec 2020 10-K 15 Mar 2022
Q3 2020 $140K -$81K -36.7% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $125K -$90K -41.9% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $149K -$7K -4.49% 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $172K +$82K +91.1% 31 Dec 2019 10-K 24 Mar 2021
Q3 2019 $221K +$131K +146% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $215K +$125K +139% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $156K +$66K +73.3% 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $90K $0 0% 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 $90K $0 0% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $90K -$281K -75.7% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $90K -$240K -72.7% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 $90K -$243K -73% 31 Dec 2017 10-K 26 Mar 2019
Q3 2017 $90K -$263K -74.5% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 $371K +$196K +112% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $330K +$230K +230% 31 Mar 2017 10-Q 11 May 2017
Q4 2016 $333K +$215K +182% 31 Dec 2016 10-K 20 Mar 2018
Q3 2016 $353K +$216K +158% 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $175K +$29K +19.9% 30 Jun 2016 10-Q 10 Aug 2016
Q1 2016 $100K -$2.8M -96.5% 31 Mar 2016 10-Q 11 May 2016
Q4 2015 $118K -$2.09M -94.7% 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 $137K 30 Sep 2015 10-Q 10 Nov 2015
Q2 2015 $146K 30 Jun 2015 10-Q 12 Aug 2015
Q1 2015 $2.9M 31 Mar 2015 10-Q 18 Jun 2015
Q4 2014 $2.21M 31 Dec 2014 10-K 30 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.